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ABSTRACT
Objective: The aim of the study was to explore how home-dwelling elderly who use fall-risk-
increasing drugs (FRIDs) perceive their fall risk and how they relate this to their drug use.
Design, setting and subjects: A qualitative study with 14 home-dwelling elderly FRID users
between 65 and 97 years in Central Norway participating in semi-structured individual inter-
views. The data were analyzed thematically by using systematic text condensation.
Results: The main finding was that the informants did not necessarily perceive the use of FRIDs
to be a prominent risk factor for falls. Some informants said they did not reflect upon drug use
whatsoever and said they fully trusted their physician’s choices. When either experiencing dizzi-
ness, fall episodes or by reading the patient information leaflet the informants said to either
adjust their drug use or to contact their physician. Some felt rejected due to not getting their
point across or their wish to alter the drug was not granted by the physician.
Conclusions: Elderly FRID users did not necessarily relate their drug use to fall risk or struggled
to present their perceived drug-related problems. Physicians need to regularly inform, monitor
and assess the drug treatment when treating elderly with FRIDs.
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Introduction
Elderly persons are more prone to falls [1] and falls are
a prominent cause of unintentional injury [2]. More
than every third person above 65 years fall each year
and the frequency increases with age and frailty level
and falls account for 40% of all injury deaths [2]. The
underlying causes of falls are multifaceted, including a
combination of biological and environmental factors
[3], e.g. aging [4], different diseases [5] and the use of
drugs [6].
The aging process involves changes that lead to
reduced homeostatic reserves and make the person
vulnerable to dizziness and other fall risk factors [4].
However, when asked, persons between 60 and 96
years old associated older age with physical and men-
tal decline, but did not necessarily consider themselves
as old except in periods when experiencing physical
decline [7].
Dizziness increases the risk of falls [5] and in elderly
over 75 years dizziness is a frequent reason for visiting
the family physician, accounting for one of 10 visits
during one year [8]. Prevalence of dizziness has been
reported by 17.5% for the age group 60–80 years and
31.0% for those above 80, with a higher prevalence in
women [9]. Studies of elderly’s experiences of living
with dizziness found that they fought to live a normal
life [10], to understand the causes [8] and also to get
accurate information in order to handle or control the
dizziness [11].
Studies on fall-related knowledge among commu-
nity-dwelling elderly show that the elderly recognize
fall-risk factors, especially exterior factors like rugs, fur-
niture and pavements, but do not consider themselves
susceptible to falling [12]. When asked to recognize
factors that affect the recognition and reflection of fall
risk, the elderly mentioned alarming experiences, grad-
ually growing insight, sharing mutual experience and
public information [13]. Older people often support
fall-prevention advice for others, but not for them-
selves [14].
Dizziness and the risk of falling significantly increase
with the number of drugs [3] especially when using
fall-risk-increasing drugs (FRIDs) like psychotropic
drugs and some drugs affecting the cardiovascular sys-
tem [6,15]. FRIDs are associated with impaired postural
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control and adverse effects like orthostatic hypoten-
sion [15]. We have not been able to find studies inves-
tigating whether elderly persons link FRID or drug use
in general with risk of falling due to, e.g. dizziness and
how they handle their drug use if they perceive there
to be a connection. The aim of the study was there-
fore to explore how home-dwelling elderly FRID users
perceive their fall risk and how they relate this to their
drug use.
Materials and methods
This was a qualitative study with individual semi-struc-
tured interviews. The data collection took place in an
urban municipality in Central Norway from May 2013
to October 2014. The Regional Committees for Medical
and Health Research Ethics of Central Norway
approved the study (2012/2163).
Setting
All residents in Norway are entitled to a regular gen-
eral practitioner (GP) for providing general healthcare
[16] and 99.6% of the population are registered with a
GP [17]. Home-dwelling elderly receive their medical
service from their GP [17], but might be prescribed
FRIDs from other physicians like hospital physicians
and other specialist physicians [17]. Norway had by
April 2016 14.1% aged 67 years or older [18]. Fall inju-
ries are ranked as the sixth most important contributor
to burden of disease in Norway ranked over cardiovas-
cular disease [19]. According to the Norwegian
Prescription Database [20], 573,000 persons above 65
years use a vasodilator drug (ATC-C01, C02CA, C08,
C09A-D). The corresponding number for neuroleptic
drugs (ATC-N05) is 258,000, respectively.
Informants
The aim was to include elderly persons living at home,
above the age of 65 that used FRIDs. To ensure vari-
ation, we included informants with a registered fall
but also elderly that both did and did not self-report a
fall or experienced dizziness. In addition, we strived to
get a variation in gender, age and FRID.
To recruit informants, several approaches were
used. The first author presented the study and distrib-
uted the information letter to the unit for Health and
Social Care at the municipality and to different senior
associations. To increase the chances of getting
informants who had registered a fall, an employed
pharmacist at the orthopedic department at the
University Hospital informed eligible patients about
the study and handed out information letters. In add-
ition, the word was spread throughout the authors’
local networks of elderly.
Data collection
Data were collected using individual face-to-face semi-
structured interviews [21] at the homes of the elderly
except one interview conducted at a recovery nursing
home. Before the interviews started, more detailed
information was given and the written consent was
signed. The interviews lasted from 21 to 87minutes.
The first author performed the interviews according
to a preset topic guide to ensure that all aspects of
interest were covered in all the interviews. The partici-
pants were also encouraged to talk freely about
related topics. The main questions in the interview
guide were as follows:
 ‘Have you experienced dizziness or falls? Can you
explain to me what happened?’
 ‘Can you tell me which medicines you are taking
and what information you have received from your
physician?’
 ‘Do you associate the use of your medicines with
dizziness and falls? Please explain’.
Data analysis
The interviews were digitally recorded, transcribed ver-
batim and analyzed using the method of systematic
text condensation (STC) [22]. STC is suitable for
descriptive transversal analysis of phenomena [21]. The
method consists of an iterative four-step process start-
ing with making four to eight preliminary topics based
on a total impression of the data. To do so, the first
author read all the transcripts and chose the three
richest transcripts, according to the aim of the study,
that were read by all authors. In the second step, the
first author went through all the data and identified
and sorted meaning units that elucidated the study
question into the preliminary topics. Then these topics
with subtopics were adjusted, refined and renamed as
a result of discussions between the three authors. This
was done in several stages. In the third step, the first
author wrote a condensate for every subtopic. The
condensate is an artificial quotation maintaining
the original terminology used by the participants. In
the last step, the first author produced an analytic text
for each subtopic based on the condensates to ensure
closeness to the original wording used by the inform-
ants. In this step, the text is reconceptualized and the
synthesized results reflect the validity and wholeness
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of their original context [22]. There were regular inputs
from the co-authors during all steps of the analyses.
During the whole process, the authors went back to
the transcripts to ensure that the analysis was based
on them. The themes and the analysis were also dis-
cussed in an extended research group to ensure
validity.
Results
A total of 14 home-dwelling elderly FRID users were
interviewed. There was an equal distribution of gender
with a mean age of 81 years. Their mean total number
of drugs and FRIDs was 6.1 and 2.1, respectively.
Further characteristics of the participants are listed in
Table 1. The findings were categorized into three main
themes that sum up the participants’ perception of fall
risk and the relations to drug use (Table 2). The
themes are as follows:
‘It is not related to drug use’
The main impression from the interviews was that the
informants did not perceive to have a particular risk of
falling. If they did, they did in general not relate this
to their drug use. None of the informants used the
word risk of falling, but rather spoke of dizziness,
unsteadiness and similar terms.
Other risk factors perceived as more prominent
Some informants did not see themselves as having
any personal risk for falling whatsoever.
I do not feel dizzy. I have a very good balance.
I actually do. (Woman 84 not dizzy/no falls)
When asked elaborating questions, some of these
informants said that in certain situations, they could
feel dizzy or unsteady. However, these informants said
that they did not necessarily perceive their fall risk as
a particularly prominent challenge. On the contrary, it
was emphasized how much they still were capable to
manage in their daily life. When asked to give more
details of what they saw as possible risks for falling,
they listed factors like worsening eyesight, different
diseases, slippery surface due to wearing socks indoors
or icy ground outdoors, weaker muscles and the per-
ception of a rigid body which hindered steadiness,
stumbling due to, e.g. furniture standing in their way
or being in a hurry.
I fell once out on the balcony. I was wearing my
slippers. It was a thin layer of ice. There was nothing
related to drug use. (Woman 85 not dizzy/no fall
injury)
Adapting everyday life instead of bothering the
physician
The informants talked about how they adapted their
everyday life to handle their fall risk. This was done
through showing a little more caution when getting
out of bed in the morning or rising from a chair, to
use stair railings or to stop performing certain activ-
ities like cross-country skiing or other sports. The rea-
son for doing so was the effort of getting up from the
floor or the ground if they had fallen.
When I get up in the morning I have to wait for
the head to get on place before I stand up. I walk
like a one year old – I guess that is how it is when
you are getting old. (Male 84, not dizzy/no fall
injury)
Table 1. Demographic characteristic of the participants.
Number
Gender
Female 7
Male 7
Age
Age range women in years (mean) 79–97 (87)
Age range men in years (mean) 66–85 (76.7)
Handling drugs themselves 12
Dizziness and fall injuries
Reported dizziness 4
Reported fall injuries 4
None of the above 6
Drugs
Range number all drug women (mean) 3–14 (7.4)
Range number all drug men (mean) 2–9 (4.7)
FRIDs
Range all FRID women (mean) 1–4 (2.4)
Range all FRID men (mean) 1–4 (2.3)
(Number of appearance among informants)
Drug classes FRIDs b-blockers (5), A II-blockers (5), Ca blockers (5), Diuretics (5), Z-hypnotics (4),
antidepressant (3), ACE inhibitors (2) and a-b-blockers (1)
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These informants said to hold back contacting a
physician when experiencing dizziness or other symp-
toms related to fall risk. When asked to give grounds for
why they refrained to address their problems, the
informants perceived the physicians as too busy or they
got the impression that they were only allowed to
express one problem at a time during their consultation.
One informant said that she did not think the physicians
always had the answer to all types of questions.
I do not know if that is something to trouble the
doctor about. (Woman 79, fall injury)
Suspecting the drug
There were informants who said they were afraid of fall-
ing and they connected this mainly to dizziness. These
informants did not settle down with the explanation of
their dizziness and/or fall episode(s) to be an accident
or caused by aging. None of the informants were famil-
iar with the term FRID and therefore spoke about their
drugs in general. They talked about how they after
experiencing repeated dizziness or fall episodes had
eliminated other plausible causes and then the idea of
the drug causing the problems had emerged. Examples
of this were, e.g. having a hangover feeling of being
heavy headed the morning after using a sleeping pill.
One informant described two scary fall episodes two
nights in a row when heading for the toilet which
made him anxious and unwilling to continue taking
sleeping pills. Another informant using an antihyper-
tensive gave a rich description on how he almost
fainted when bending down to tie his shoes.
Informants experiencing similar episodes expressed a
wish to understand the causes of their perceived dizzi-
ness or unsteadiness since this gave rise to fear of new
fall episodes or stress due to not being able to predict
the next episode.
It is the dizziness that bothers me the most (… ) I
believe for sure that it has to do with the drugs.
(Man 78, dizzy)
Information about drug as a fall risk factor
One of the informants said that he could recall his GP
informing him about dizziness as a side effect of the
FRID and to regularly ask him whether he felt dizzy.
However, to be informed by physicians of other side
effects like addiction from, i.e. sleeping pills was more
common.
Regardless of information from their physician,
most patients always read the patient information leaf-
lets (PILS). This information was at times frightening
and gave rise to new questions, especially for those
who expressed concerns about side effects. One
informant explained how he always read through the
information leaflets when he was prescribed a new
drug in search of description of dizziness. For inform-
ants talking about an association between dizziness
and drug use, the role of the PILS was central, but
they did not necessarily have a clear opinion of what
came first. They could either read the leaflet and then
becoming aware of their dizziness, or they felt dizzy
and then connected this to information in the PILS.
It is not the smartest thing to read the information
leaflets, because they can scare you to not dare to
take any medicine. What I have found out about side
effects I have read myself… . (Man 70, dizzy/fall injury)
Some informants mentioned their local pharmacist
or someone from their social network using the same
drug as the ones making them aware of drugs as a
risk factor for falls. When suspecting the drug to be
the cause and presenting this as a problem at the
pharmacy, the pharmacist was said to come forward
as an information source confirming their suspicion
and to elaborate the information from the drug leaflet.
One informant underlined that you cannot necessarily
trust information about side effects in your social net-
work since all experience drugs differently.
Adjusting drug use by themselves
There were informants who said they modified their
drug use without contacting their physician when sus-
pecting their drug. One informant said she had started
taking her antihypertensive at bedtime instead of in
the morning to avoid feeling tired during the day
when reading in the PILS that the drug could cause
drowsiness. Another informant described how he felt
unwell and confused after using a psychotropic drug
for his sleeping problems and therefore had to stop
Table 2. Overview of findings.
Main theme Subthemes
‘It is not related to drug use’ Other risk factors perceived as more prominent
Adapting everyday life instead of bothering the physician
Suspecting the drug Information about drug as a fall risk factor
Adjusting drug use by themselves
Communication with the physician about drug use ‘I trust my physician when it comes to drugs’.
Feeling rejected by the physician when presenting a problem
The trade-off between the effect and side effect
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taking the drug. The same informant was later pre-
scribed another type of sleeping pill where he after a
while adjusted the dose without informing his phys-
ician mainly due to the wish of sleeping naturally,
but also because of feeling heavy headed in the
morning.
The morning after taking a sleeping pill (… ) it can be
like when you drink alcohol and gets too much of it
and then when you get up the next morning.
(Man 79, dizzy)
Communication with the physician about drug use
There were informants who said they did not talk spe-
cifically about the drugs with the physicians because
they trusted their physician, while others wished for
their prescriber to always go into details about the
drug’s potential side effects. It was variation in how
much they said they knew about the purpose of their
drugs, ranging from the ones who took what was pre-
scribed without knowing specifically or had miscon-
ceptions to why the drug was prescribed to those that
had detailed knowledge. The informants did not
always know the name of their FRID, neither brand
name nor generic name, but did recognize the drug’s
therapeutic category like, e.g. ‘high blood pressure’ or
‘sleeping pill’.
I am not sure if it is for my heart – is it? (Woman 97,
fall injury)
I trust my physician when it comes to drugs
The reason given for trusting their physician was that
physicians are well educated and this makes their
choices trustworthy. Furthermore, to prescribe and
treat was said to be the physician’s responsibility and
not theirs. They therefore accepted a drug even
though they not always understood why treatment
was initiated. They did not necessarily have that many
expectations of any additional information about their
drug during the consultation beyond the written
instruction on the label that was perceived as enough
information.
I guess I get the information I need, but maybe I
should have asked more questions… . I have just
accepted it, because I fully trust my GP. I do not have
an opinion (… ) because that is up to the GP to
decide. It is his responsibility. (Woman 79, fall injury)
As the citation shows, there were also informants
who said that it might not solely be the physician’s
job to inform during the consultation but just as well
their responsibility to ask more questions.
Feeling rejected by the physician when presenting a
problem
The informants said it sometimes was difficult to get
your point across when presenting a diffuse bodily dis-
comfort perceived to affect their quality of life to the
physician or when asking more specifically whether
their drug could cause their fall risk. Sometimes the
physician refrained to make any changes, arguing
there were no alternatives. Informants perceived this
as being rebuffed and were not satisfied with the
answer or the argumentation given. In particular, this
concerned informants using statins that caused muscle
pain and restless legs perceived to affect their balance.
One of them felt rejected by his GP when he asked
whether his statin could cause his muscle aches. He
thereby asked his local pharmacist who encouraged
him to present the symptoms to the GP once again.
The other patient, taking a maximum dosage of a sta-
tin, said she had failed to make her GP understand
why she had a tingling and stinging pain in her feet
and therefor said she had given up to resolve her
symptoms. This informant said she did not feel dizzy
and emphasized that it was her body and not her
head that had caused her two fall injuries.
I asked my GP once ‘Can you please explain to me
why I get this stinging feeling in my legs? It feels like
there is something walking around in my veins’. He
could not give me an answer and then he did not talk
more about it. It might just be aging, but I find it
strange that it moves around and stop when I touch
my leg. (Woman 79, fall injury)
The trade-off between the effect and side effect
When the physicians did acknowledge the informants’
complaints as drug related, the physician either
reduced the dose straight away or left it to the patient
to reduce the dose or to stop the drug altogether. The
physician could ask the patients whether they still
were in need of their drug when experiencing severe
side effects. When asked the same question during the
interview, there were informants that pointed at the
contrast of a perceived need of the drug to be able to
live their lives but at the same time the unpleasant
experience of the drug to affect their risk of falling.
I believe that if I had not taken sleeping pills I would
have felt worse in the morning. (Woman 89, fall injury)
In some cases, the informants said they were asked
by their physician to themselves regulate the dose to
balance effect and side effect. One informant
described the relief he felt when his drug calmed his
galloping heart allowing him to sleep at night, but at
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the same time how he struggled with dizziness during
daytime. This patient did not appreciate to be given
such a responsibility and therefore perceived the
trade-off between the wanted effects against the
unpleasant side effect as a dilemma.
When the hospital physician called me back I told him
that the metoprolol is affecting my quality of life and
make me anxious about when the dizziness will
emerge. (… ) He understood me and said ‘that is why
we need to do something about it’. He told med I
could reduce the dose to 25mg, but it was up to me.
(… ) I want to discuss it with my GP first so that I
don’t have to make the decision entirely on my own.
(Man 66, dizzy)
Discussion
The overall impression was that the informants saw
aging and external factors as more plausible risk fac-
tors for falls than drugs. Those who suspected their
drug to affect their fall risk said the suspicion had
grown upon them after either experiencing severe diz-
ziness or fall episodes or after reading the PILS. It was
rarely connected to being informed by health person-
nel or someone in their social network. It was common
to trust the physician and to not reflect much upon
drugs and drug use. However, when presenting either
with a wish to find a cause, alter or discontinue the
drug a feeling of rejection could occur when they felt,
they did not get their point across. It was also per-
ceived as a dilemma to be given the responsibility to
be the one to balance effect and side effect by choos-
ing themselves how much medicine they should take.
Strength and limitations
We found both new perspectives and confirmations in
the literature of our findings that ensured the validity
of our results. Furthermore, the narrow aim and the
diversity of eligible informants regarding gender, age
and number of drugs in addition to comprise inform-
ants who both had and had not experienced dizziness
and falls gave this study sample a high information
power [23]. However, only four of the informants had
experienced fall injury and an additional four reported
dizziness that can be perceived as a limitation of the
sample. Additionally, the interviewees had an interest
in the subject that might affect the transferability of
the findings due to the limitation in the diversity of
the perspectives. However, all interviews, except one,
were conducted at the elderlies’ homes in addition to
the interviewer being a pharmacist with long experi-
ence talking to elderly patients that contributed to a
relaxed atmosphere assuring good quality dialogues.
The analysis was performed by three researches with
different backgrounds that contributed to different
perspectives. In addition, the results were discussed in
an extended research group that also strengthened
the validity.
In need of information – perception of fall risk
and knowledge of drugs
The main finding was that the informants in our study
did not consider drug use to be a prominent factor for
fall risk, but recognized other causes to be more plaus-
ible. The underlying causes of falls are multifaceted [2]
and the informants identified known risk factors like
aging [4], muscle and neurological diseases [3], and
environmental factors like furniture, carpets and slip-
pery surface [2] as risk factors for falls. To not consider
themselves susceptible to falls and to mainly recognize
exterior factors to cause falls [12] and to fight for a
normal life style when occasionally feeling dizzy have
also been found by others [10]. This is in line with the
finding that some of our informants downplayed their
fall risk [13] or dizziness [8] since they were eager to
emphasize what they still managed in everyday life.
Another reason might be that some of them did not
remember having fallen [24]. Even if several informants
did not see themselves at risk of falling when first
asked, they did take precautions through making phys-
ical adaptions in everyday life or gave up certain activ-
ities. Thus, at least when asked elderly persons have
an awareness of fall risk, but based on this study do
not consider drugs to be a prominent factor.
Between 60 and 70% of elderly outpatients above
65 years have been found to be aware of their drug’s
name and purpose [25–27]. However, the knowledge
of the side effects is found to be poorer with 4–12%
[26–28] correctly identifying them. This is one possible
reason for why the informants in our study did not
think of drug use as a risk for falling. The expressed
need for information of side effects was not particu-
larly present in our study and is in contrast to others’
findings, where all patients mentioned a wish for a full
disclosure of information of side effects [29]. Some of
the informants who showed little interest in why they
took their drugs said to fully rely on their physician’s
treatment decisions, indicating a wish for a physician-
directed style of care [30]. This could constitute a
problem as patients who are not familiar with side
effects of their drugs have a higher risk of serious
complications [27]. This is in addition to some of our
informants who said that the PILS that follows
the medicine package could evoke fear [31] and
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anxiety [32]. Since such fear can lead to the elderly
consulting their GP for assistance and a wish for indi-
vidual judgment [31], it is important that patients
regularly get individualized information of their drugs’
common side effects so that they know when to seek
help, e.g. experiencing dizziness when using FRIDs.
How to unveil whether the FRID causes problems
Even if our informants did not identify drugs in gen-
eral or FRIDs in particular as increasing fall risk, there
is good documentation of such a connection.
Psychotropic drugs like benzodiazepines [33], neuro-
leptic drugs [6,34] and hypnotic z-drugs [35,36] have
been linked to falls even when adjusted for chronic
disease status [37,38]. In addition, vasodilator drugs
increase the risk of falls [39,40]. However, statins that
were said by some of our informants to be the cause
of their unsteadiness are in some literature not linked
to fall risk [41]. However, there is suggestive evidence
that these drugs may affect muscle strength in older
patients [41]. According to the Norwegian guidelines
for treatment and rehabilitation, the effectiveness of
statin treatment for elderly above 80 years is weak
and individual assessment is recommended [42].
Regardless the drug being known as causing fall risk,
physicians need to be alert when patients reports
complaints perceived to affect their fall risk.
Some of our informants said they struggled to get
their point across when presenting their bodily dis-
comfort to their physician [43]. Elderly also often pre-
sent complex problems [44,45] and in one-third of the
consultations of older patients, the physician did not
recognize the patient’s complaints or gave other
health problems a higher priority than the patient [45].
If patients then both do not relate drug use to fall risk
and in addition struggle to describe and present what
could be a side effect of FRIDs during consultations,
there is a need for physicians to be aware of these
challenges.
We have in a previous qualitative study found that
general practitioners rarely consider fall risk when issu-
ing repeat prescriptions of FRIDs unless patients report
symptoms like dizziness or falls [44]. When this is con-
sidered in light of the present study where our inform-
ants did not connect drugs and fall risk and also
struggled to present what could be a side effect, it
raises the question about how the connection
between drugs and fall risk then can be noticed. One
answer is for physicians to systematically use evi-
dence-based guidelines and tools like START/STOPP
criteria where there is a specific section (section K)
that lists drugs that predictably increase risk of
falls [46]. Not all general practitioners are familiar with
the START/STOPP criteria [44,46] and barriers to use
the tool have been identified by GPs [47].
Another solution to the challenge of systematically
identifying drugs that increases risk of falling could be
to encourage the physicians to perform regular and
thorough drug assessment like systematic drug
reviews as described in the integrated medicine man-
agement (IMM) model [48]. A thorough anamnesis,
regular blood pressure control and regular drug
reviews have been suggested to be obligatory tasks to
prevent falls in all parts of the healthcare system [49].
Especially, interprofessional drug reviews with muliti-
disciplinary case conferences where the different pro-
fessions meet and discuss the physician can get
decision support through increased knowledge and
critical reflections on the ongoing drug treatment [50].
Elderly FRID users do not necessarily relate their drug
use to fall risk. Some struggle to verbalize their perceived
drug-related problems to their physician. Physicians
should regularly inform, monitor and assess the drug
treatment when treating elderly with FRIDs to make sure
they recognize side effects like dizziness and falls.
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